Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

VELAGLUCERASE ALFA: Who Reports Side Effects? Age, Gender & Country Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Gender Distribution

51.6%
Female
48.4%
Male

Age Information

The average age of patients reporting adverse events with VELAGLUCERASE ALFA is 44.7 years.

Geographic Distribution

The majority of adverse event reports for VELAGLUCERASE ALFA originate from US.

Report Summary & Outcomes

1,745
Total Reports
1,745
As Primary/Secondary Suspect
229
Deaths Reported
771
Hospitalizations
50
Life-Threatening
23
Disabilities

Reporting Timeline

First adverse event report: 19951115. Most recent report: 20250910. View full timeline →

More About VELAGLUCERASE ALFA

VELAGLUCERASE ALFA Full Profile Reports by Year Drug Interactions